These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30913362)

  • 1. A cross-sectional follow-up study of physical morbidities, neurocognitive function, and attention problems in post-treatment childhood acute lymphoblastic leukemia survivors.
    Chiou SS; Lin PC; Liao YM; Yang P
    Kaohsiung J Med Sci; 2019 Jun; 35(6):373-378. PubMed ID: 30913362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
    Liu W; Cheung YT; Conklin HM; Jacola LM; Srivastava D; Nolan VG; Zhang H; Gurney JG; Huang IC; Robison LL; Pui CH; Hudson MM; Krull KR
    J Cancer Surviv; 2018 Jun; 12(3):398-406. PubMed ID: 29484542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
    Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
    J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain Activity Associated With Attention Deficits Following Chemotherapy for Childhood Acute Lymphoblastic Leukemia.
    Fellah S; Cheung YT; Scoggins MA; Zou P; Sabin ND; Pui CH; Robison LL; Hudson MM; Ogg RJ; Krull KR
    J Natl Cancer Inst; 2019 Feb; 111(2):201-209. PubMed ID: 29790971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.
    Sands SA; Harel BT; Savone M; Kelly K; Vijayanathan V; Welch JG; Vrooman L; Silverman LB; Cole PD
    Support Care Cancer; 2017 Feb; 25(2):449-457. PubMed ID: 27726029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention and executive functioning in children and adolescents treated for high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group (COG).
    Hardy KK; Embry L; Kairalla JA; Sharkey C; Gioia AR; Griffin D; Berger C; Weisman HS; Noll RB; Winick NJ
    Pediatr Blood Cancer; 2024 Nov; 71(11):e31179. PubMed ID: 39175358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory.
    Langer T; Martus P; Ottensmeier H; Hertzberg H; Beck JD; Meier W
    Med Pediatr Oncol; 2002 May; 38(5):320-8. PubMed ID: 11979456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only.
    Kanellopoulos A; Andersson S; Zeller B; Tamnes CK; Fjell AM; Walhovd KB; Westlye LT; Fosså SD; Ruud E
    Pediatr Blood Cancer; 2016 Jan; 63(1):133-8. PubMed ID: 26312396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study.
    Mulrooney DA; Hyun G; Ness KK; Bhakta N; Pui CH; Ehrhardt MJ; Krull KR; Crom DB; Chemaitilly W; Srivastava DK; Relling MV; Jeha S; Green DM; Yasui Y; Robison LL; Hudson MM
    Lancet Haematol; 2019 Jun; 6(6):e306-e316. PubMed ID: 31078468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.
    Cheung YT; Edelmann MN; Mulrooney DA; Green DM; Chemaitilly W; John N; Robison LL; Hudson MM; Krull KR
    Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1259-67. PubMed ID: 27345588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing neurocognitive late effects in childhood leukemia survivors using a combination of neuropsychological and cognitive neuroscience measures.
    Van Der Plas E; Erdman L; Nieman BJ; Weksberg R; Butcher DT; O'connor DL; Aufreiter S; Hitzler J; Guger SL; Schachar RJ; Ito S; Spiegler BJ
    Child Neuropsychol; 2018 Nov; 24(8):999-1014. PubMed ID: 29017430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cross-sectional Study of Two Chemotherapy Protocols on Long Term Neurocognitive Functions in Egyptian Children Surviving Acute Lymphoblastic Leukemia.
    Sherief LM; Sanad R; ElHaddad A; Shebl A; Abdelkhalek ER; Elsafy ER; Hassan TH; Raafat N; Kamal NM; Attia EI
    Curr Pediatr Rev; 2018; 14(4):253-260. PubMed ID: 30381081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia.
    Kunin-Batson A; Kadan-Lottick N; Neglia JP
    Psychooncology; 2014 Jun; 23(6):692-9. PubMed ID: 24497266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connectivity of the Cerebello-Thalamo-Cortical Pathway in Survivors of Childhood Leukemia Treated With Chemotherapy Only.
    Phillips NS; Kesler SR; Scoggins MA; Glass JO; Cheung YT; Liu W; Banerjee P; Ogg RJ; Srivastava D; Pui CH; Robison LL; Reddick WE; Hudson MM; Krull KR
    JAMA Netw Open; 2020 Nov; 3(11):e2025839. PubMed ID: 33216140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia.
    Kadan-Lottick NS; Brouwers P; Breiger D; Kaleita T; Dziura J; Northrup V; Chen L; Nicoletti M; Bostrom B; Stork L; Neglia JP
    J Clin Oncol; 2009 Dec; 27(35):5986-92. PubMed ID: 19884541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood leukemia survivors exhibit deficiencies in sensory and cognitive processes, as reflected by event-related brain potentials after completion of curative chemotherapy: A preliminary investigation.
    Brace KM; Lee WW; Cole PD; Sussman ES
    J Clin Exp Neuropsychol; 2019 Oct; 41(8):814-831. PubMed ID: 31156064
    [No Abstract]   [Full Text] [Related]  

  • 18. Cognitive and behavioral risk factors for low quality of life in survivors of childhood acute lymphoblastic leukemia.
    van der Plas E; Spencer Noakes TL; Butcher DT; Weksberg R; Galin-Corini L; Wanstall EA; Te P; Hopf L; Guger S; Hitzler J; Schachar RJ; Ito S; Nieman BJ
    Pediatr Res; 2021 Aug; 90(2):419-426. PubMed ID: 33203967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.
    Harila MJ; Winqvist S; Lanning M; Bloigu R; Harila-Saari AH
    Pediatr Blood Cancer; 2009 Aug; 53(2):156-61. PubMed ID: 19405135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DIVERGT screening procedure predicts general cognitive functioning in adult long-term survivors of pediatric acute lymphoblastic leukemia: A PETALE study.
    Boulet-Craig A; Robaey P; Laniel J; Bertout L; Drouin S; Krajinovic M; Laverdière C; Sinnett D; Sultan S; Lippé S
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27259. PubMed ID: 29797640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.